MetLife Collaborates With General Atlantic to Launch Chariot Re

11.12.24 19:10 Uhr

Werte in diesem Artikel
Aktien

0,06 EUR 0,00 EUR 7,48%

76,81 EUR -0,40 EUR -0,52%

Indizes

PKT PKT

16.792,5 PKT -32,7 PKT -0,19%

2.971,6 PKT -6,1 PKT -0,21%

6.050,6 PKT -23,5 PKT -0,39%

MetLife, Inc. MET and General Atlantic recently announced Chariot Reinsurance, Ltd., a Bermuda-based life and annuity reinsurer set to launch in 2025. The formation of Chariot Re, supported by more than $1 billion in equity investment, is poised to provide MetLife significant benefits as it will have a future reinsurance partnership with MetLife.This move bodes well for MET, as it will transfer approximately $10 billion in liabilities to Chariot Re, allowing it to optimize its balance sheet by freeing up capital. Transfer of some risk to another insurer will allow MET to reduce its risk exposure. This capital efficiency strengthens MetLife’s financial flexibility and positions the company to reinvest in areas that promise higher returns or deliver direct value to shareholders. MET and General Atlantic will initially hold 15% each of Chariot Reinsurance. Chubb will hold the remaining equity interests as an anchor third-party investor.Additionally, MetLife will exclusively manage Chariot Re’s investment portfolio through its asset management arm, MetLife Investment Management. This arrangement introduces a new revenue stream, leveraging MetLife’s expertise in handling complex portfolios that span fixed income, private credit and real estate. These activities are expected to contribute positively to the company’s top line in the near term.This is a time opportune move, given the rising global demand for life insurance, reinsurance, and retirement solutions. MET can capitalize on this demand through innovative reinsurance solutions. MET’s origination capabilities and General Atlantic’s leadership in private markets are likely to aid Chariot Re in achieving sustainable growth in the long term.MET’s Price PerformanceMetLife’s shares have gained 9.4% in the past three months, outperforming 5.3% growth of the industry.Image Source: Zacks Investment ResearchMET’s Zacks RankMetLife currently has a Zacks Rank #4 (Sell).Stocks to ConsiderSome better-ranked stocks in the Finance space are BrightSphere Investment Group Inc. BSIG, First Savings Financial Group, Inc. FSFG and CNO Financial Group, Inc. CNO. While BrightSphere and First Savings presently sport a Zacks Rank #1 (Strong Buy), CNO Financial carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.BrightSphere Investment’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 20.07%. The Zacks Consensus Estimate for BSIG’s 2024 earnings indicates a rise of 45.5%, while the consensus mark for revenues implies growth of 16.6% from the corresponding year-ago figures. The consensus mark for BSIG’s 2024 earnings has moved 12.1% north in the past 60 days.The bottom line of First Savings Financial beat estimates in three of the trailing four quarters and missed the mark once, the average surprise being 11.60%. The Zacks Consensus Estimate for FSFG’s 2024 earnings implies an improvement of 55.9%, while the consensus mark for revenues indicates growth of 8.5% from the corresponding year-ago figures. The consensus mark for FSFG’s 2024 earnings has moved 20.5% north in the past 60 days.The bottom line of CNO Financial beat estimates in three of the trailing four quarters and missed the mark once, the average surprise being 24.5%. The Zacks Consensus Estimate for CNO’s 2024 earnings implies an improvement of 20.7%, while the consensus mark for revenues indicates a decline of 10.5% from the corresponding year-ago figures. The consensus mark for CNO’s 2024 earnings has moved 2.8% north in the past 30 days.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CNO Financial Group, Inc. (CNO): Free Stock Analysis Report MetLife, Inc. (MET): Free Stock Analysis Report First Savings Financial Group, Inc. (FSFG): Free Stock Analysis Report BrightSphere Investment Group Inc. (BSIG): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Chariot

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Chariot

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"